Abstract
Presentation Description :
Presently, multiple strategies have been demonstrated to slow the progression of myopia. The use of such strategies is increasingly becoming mainstream clinical practice. However, we are becoming aware of some unique challenges when exploring and assessing newer strategies or mechanisms underlying the efficacy of these strategies. For example, their efficacy is typically assessed using randomized test and control groups, a methodology that raises questions related to duration, use of controls, applicability to other populations etc. This talk will highlight some of these important questions.
This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.